AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 48 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,142,236 | -20.9% | 8,263,982 | 0.0% | 2.21% | -17.5% |
| Q2 2023 | $141,727,291 | -15.0% | 8,263,982 | 0.0% | 2.68% | -29.1% |
| Q1 2023 | $166,684,517 | -31.2% | 8,263,982 | 0.0% | 3.77% | -23.2% |
| Q4 2022 | $242,134,673 | +76.7% | 8,263,982 | 0.0% | 4.91% | +68.0% |
| Q3 2022 | $137,017,000 | +6.1% | 8,263,982 | 0.0% | 2.92% | -15.1% |
| Q2 2022 | $129,166,000 | -14.7% | 8,263,982 | 0.0% | 3.44% | +4.2% |
| Q1 2022 | $151,479,000 | +55.5% | 8,263,982 | 0.0% | 3.30% | +92.4% |
| Q4 2021 | $97,432,000 | -43.8% | 8,263,982 | 0.0% | 1.72% | -28.5% |
| Q3 2021 | $173,378,000 | -8.1% | 8,263,982 | 0.0% | 2.40% | -20.7% |
| Q2 2021 | $188,667,000 | – | 8,263,982 | – | 3.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $8,193,050 | 18.42% |
| TCG Crossover Management, LLC | 2,201,274 | $29,871,288 | 4.40% |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27,672,609 | 4.29% |
| Sofinnova Investments, Inc. | 3,758,686 | $51,005,369 | 3.22% |
| GREAT POINT PARTNERS LLC | 1,091,233 | $14,808,032 | 2.70% |
| RA Capital Management | 8,263,982 | $112,142,236 | 2.21% |
| Cormorant Asset Management, LP | 1,561,696 | $21,192,215 | 1.24% |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $16,350,045 | 1.09% |
| Octagon Capital Advisors LP | 497,370 | $6,749,311 | 1.04% |
| Ghost Tree Capital, LLC | 201,197 | $2,730,243 | 0.90% |